跳至主要内容
临床试验/CTRI/2024/05/067079
CTRI/2024/05/067079尚未招募2/3 期

A single arm clinical study to evaluate the efficacy of nagkesar with amalaki varti in the management of raktaja arsha (bleeding haemorrhoids)

Dr Sagar Verma1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2024年5月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
31
试验地点
1
主要终点
To study the Raktstambhana properties of Nagkesar with Amalaki Varti in Raktaja Arsha

研究概览

简要总结

A single arm clinical study to evaluate the efficacy of Nagkesar with Amalaki Varti in the management of Raktaja Arsha (Bleeding Haemorrhoids). To observe the raktstambhana property of Nagkesar and Amalaki Varti in the management of Raktaja Arsha. Total 31 patients diagnosed with Raktaja Arsha Will be administered with Varti prepared from Nagkesar with Amalaki twice a day for 7 days . Assesment will be done on 0 , 3rd and 6th day and conclusion will be drawn on the basis of statistical method.

研究设计

研究类型
Interventional
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient diagnosed with 1st and 2nd Degree Raktaja Arsha 2) Patient having signs & symptoms of Raktaja Arsha as mentioned by ‘Acharya Sushruta’ ➢ Sarakta malapravrutti (Bleeding while defecation) ➢ Savedana or Avedana mal nishkasan (Defecation with or without pain).

排除标准

  • Patient not willing for trial.
  • Pregnant women.
  • Known case of – Severe Anemia, Ulcerative Colitis , Crohns disease, Tuberculosis of Colon & Rectum , Rectal Prolapse , Rectal cancer.

结局指标

主要结局

To study the Raktstambhana properties of Nagkesar with Amalaki Varti in Raktaja Arsha

时间窗: Assessment will be done on 0th,3rd and 6th day.

次要结局

  • To study the adverse effect of varti prepared from Nagkesar with Amalaki in Raktaja arsha .(On completion of the treatment.)

研究者

发起方
Dr Sagar Verma
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sagar Verma

Dr D Y Patil College Of Ayurved And Research Centre Sant Tukaram Nagar Pimpri Pune 18

研究点 (1)

Loading locations...

相似试验